Ontology highlight
ABSTRACT:
SUBMITTER: Castillo-Mancilla JR
PROVIDER: S-EPMC3374961 | biostudies-literature | 2012 Mar
REPOSITORIES: biostudies-literature
Castillo-Mancilla Jose R JR Campbell Thomas B TB
Journal of comparative effectiveness research 20120301 2
Efavirenz (EFV) is a non-nucleoside widely used as first-line therapy for HIV-1 infection. Most of the research available on EFV comes from trials performed in industrialized countries and only a few studies have evaluated EFV in resource-limited settings (RLSs). In this article, we present a systematic review of the available randomized-controlled trials performed in RLSs that have compared EFV with other antiretrovirals, such as nevirapine and protease inhibitors. The data derived from these s ...[more]